NewGenIvf (NIVF) CMO Tina Fong Receives Stock Option Award

What Happened

• Tina Fong, Chief Marketing Officer and Director of NewGenIvf Group Ltd (NIVF), was granted options to acquire 272,140 Class B ordinary shares. The Form 4 reports the acquisition as a derivative award (code A) with an acquisition amount of $0.00; the option exercise price is US$0.0001 per share (per footnote).
• The options vest upon grant and expire on August 17, 2033 (7 years from the grant date), subject to earlier termination under the company’s 2024 Share Incentive Plan and the Option Agreement dated August 17, 2026.

Key Details

• Transaction date: August 17, 2026; Form 4 filed August 18, 2026 (filed the next day).
• Instrument: Stock options (derivative award) to acquire 272,140 Class B ordinary shares.
• Exercise price: US$0.0001 per share; Form 4 reports acquisition value $0.00.
• Vesting/expiration: Vests immediately; expires August 17, 2033 (subject to plan/agreement terms).
• Shares owned after transaction: Not disclosed on the Form 4.
• Footnote: Grant made under the Issuer’s 2024 Share Incentive Plan and Employee Stock Option Agreement dated August 17, 2026.
• No indication of sale, exercise, or tax withholding in this filing.

Context

• These are stock option awards (not an open‑market purchase). Because the options vest immediately, the holder can potentially exercise them (subject to the agreement), but this filing only reports the grant—there’s no exercise or sale reported. Awards like this are common as employee/director compensation and do not by themselves indicate immediate buying or selling in the market.